“Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review”, Mol. Med. Com., vol. 5, no. 1, pp. 17–28, Jun. 2025, doi: 10.55627/mmc.005.01.01795.